Matches in Nanopublications for { ?s ?p "[Comprehensive genomic profiling of relapsed CDH1-mutated ILC revealed actionable genomic alterations in 86% of cases, featured a high incidence of ERBB2 alterations, and can reveal actionable alterations that can inform treatment decisions for patients with ILC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[Comprehensive genomic profiling of relapsed CDH1-mutated ILC revealed actionable genomic alterations in 86% of cases, featured a high incidence of ERBB2 alterations, and can reveal actionable alterations that can inform treatment decisions for patients with ILC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Comprehensive genomic profiling of relapsed CDH1-mutated ILC revealed actionable genomic alterations in 86% of cases, featured a high incidence of ERBB2 alterations, and can reveal actionable alterations that can inform treatment decisions for patients with ILC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_assertion description "[Comprehensive genomic profiling of relapsed CDH1-mutated ILC revealed actionable genomic alterations in 86% of cases, featured a high incidence of ERBB2 alterations, and can reveal actionable alterations that can inform treatment decisions for patients with ILC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_provenance.
- NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_assertion description "[Comprehensive genomic profiling of relapsed CDH1-mutated ILC revealed actionable genomic alterations in 86% of cases, featured a high incidence of ERBB2 alterations, and can reveal actionable alterations that can inform treatment decisions for patients with ILC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_provenance.
- NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_assertion description "[Comprehensive genomic profiling of relapsed CDH1-mutated ILC revealed actionable genomic alterations in 86% of cases, featured a high incidence of ERBB2 alterations, and can reveal actionable alterations that can inform treatment decisions for patients with ILC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_provenance.